Search

Your search keyword '"Petrova, Dafina"' showing total 412 results
Start Over Author "Petrova, Dafina"
412 results on '"Petrova, Dafina"'

1. Association of body shape phenotypes and body fat distribution indexes with inflammatory biomarkers in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank

Author

González-Gil, Esther M., Peruchet-Noray, Laia, Sedlmeier, Anja M., Christakoudi, Sofia, Biessy, Carine, Navionis, Anne-Sophie, Mahamat-Saleh, Yahya, Jaafar, Rola F., Baurecht, Hansjörg, Guevara, Marcela, Etxezarreta, Pilar Amiano, Verschuren, W. M. Monique, Boer, Jolanda M. A., Olsen, Anja, Tjønneland, Anne, Simeon, Vittorio, Castro-Espin, Carlota, Aune, Dagfinn, Heath, Alicia K., Gunter, Marc, Colorado-Yohar, Sandra M., Zilhão, Nuno R., Dahm, Christina C., Llanaj, Erand, Schulze, Matthias B., Petrova, Dafina, Sieri, Sabina, Ricceri, Fulvio, Masala, Giovanna, Key, Tim, Viallon, Vivian, Rinaldi, Sabina, Freisling, Heinz, and Dossus, Laure

Published
2024
Full Text
View/download PDF

2. Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries

Author

Tong, Tammy Y. N., Clarke, Robert, Schmidt, Julie A., Huybrechts, Inge, Noor, Urwah, Forouhi, Nita G., Imamura, Fumiaki, Travis, Ruth C., Weiderpass, Elisabete, Aleksandrova, Krasimira, Dahm, Christina C., van der Schouw, Yvonne T., Overvad, Kim, Kyrø, Cecilie, Tjønneland, Anne, Kaaks, Rudolf, Katzke, Verena, Schiborn, Catarina, Schulze, Matthias B., Mayen-Chacon, Ana-Lucia, Masala, Giovanna, Sieri, Sabina, de Magistris, Maria Santucci, Tumino, Rosario, Sacerdote, Carlotta, Boer, Jolanda M. A., Verschuren, W. M. Monique, Brustad, Magritt, Nøst, Therese Haugdahl, Crous-Bou, Marta, Petrova, Dafina, Amiano, Pilar, Huerta, José María, Moreno-Iribas, Conchi, Engström, Gunnar, Melander, Olle, Johansson, Kristina, Lindvall, Kristina, Aglago, Elom K., Heath, Alicia K., Butterworth, Adam S., Danesh, John, and Key, Timothy J.

Published
2024
Full Text
View/download PDF

3. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.

Author

Gaziano, Liam, Sun, Luanluan, Arnold, Matthew, Bell, Steven, Cho, Kelly, Kaptoge, Stephen, Song, Rebecca, Burgess, Stephen, Posner, Daniel, Mosconi, Katja, Robinson-Cohen, Cassianne, Mason, Amy, Bolton, Thomas, Tao, Ran, Allara, Elias, Schubert, Petra, Chen, Lingyan, Staley, James, Staplin, Natalie, Altay, Servet, Amiano, Pilar, Arndt, Volker, Ärnlöv, Johan, Barr, Elizabeth, Björkelund, Cecilia, Boer, Jolanda, Brenner, Hermann, Casiglia, Edoardo, Chiodini, Paolo, Cooper, Jackie, Coresh, Josef, Cushman, Mary, Dankner, Rachel, Davidson, Karina, de Jongh, Renate, Donfrancesco, Chiara, Engström, Gunnar, Freisling, Heinz, de la Cámara, Agustín, Gudnason, Vilmundur, Hankey, Graeme, Hansson, Per-Olof, Heath, Alicia, Hoorn, Ewout, Imano, Hironori, Jassal, Simerjot, Kaaks, Rudolf, Katzke, Verena, Kauhanen, Jussi, Kiechl, Stefan, Koenig, Wolfgang, Kronmal, Richard, Kyrø, Cecilie, Lawlor, Deborah, Ljungberg, Börje, MacDonald, Conor, Masala, Giovanna, Meisinger, Christa, Melander, Olle, Moreno Iribas, Conchi, Ninomiya, Toshiharu, Nitsch, Dorothea, Nordestgaard, Børge, Onland-Moret, Charlotte, Palmieri, Luigi, Petrova, Dafina, Garcia, Jose, Rosengren, Annika, Sacerdote, Carlotta, Sakurai, Masaru, Santiuste, Carmen, Schulze, Matthias, Sieri, Sabina, Sundström, Johan, Tikhonoff, Valérie, Tjønneland, Anne, Tong, Tammy, Tumino, Rosario, Tzoulaki, Ioanna, van der Schouw, Yvonne, Monique Verschuren, W, Völzke, Henry, Wallace, Robert, Wannamethee, S, Weiderpass, Elisabete, Willeit, Peter, Woodward, Mark, Yamagishi, Kazumasa, Zamora-Ros, Raul, Akwo, Elvis, Pyarajan, Saiju, Gagnon, David, Tsao, Philip, Muralidhar, Sumitra, Edwards, Todd, Damrauer, Scott, Joseph, Jacob, Pennells, Lisa, Wilson, Peter, and Harrison, Seamus

Subjects
cardiovascular diseases, coronary disease, kidney diseases, stroke, Humans, Mendelian Randomization Analysis, Prospective Studies, Cardiovascular Diseases, Coronary Disease, Risk Factors, Diabetes Mellitus, Stroke, Kidney
Abstract

BACKGROUND: End-stage renal disease is associated with a high risk of cardiovascular events. It is unknown, however, whether mild-to-moderate kidney dysfunction is causally related to coronary heart disease (CHD) and stroke. METHODS: Observational analyses were conducted using individual-level data from 4 population data sources (Emerging Risk Factors Collaboration, EPIC-CVD [European Prospective Investigation into Cancer and Nutrition-Cardiovascular Disease Study], Million Veteran Program, and UK Biobank), comprising 648 135 participants with no history of cardiovascular disease or diabetes at baseline, yielding 42 858 and 15 693 incident CHD and stroke events, respectively, during 6.8 million person-years of follow-up. Using a genetic risk score of 218 variants for estimated glomerular filtration rate (eGFR), we conducted Mendelian randomization analyses involving 413 718 participants (25 917 CHD and 8622 strokes) in EPIC-CVD, Million Veteran Program, and UK Biobank. RESULTS: There were U-shaped observational associations of creatinine-based eGFR with CHD and stroke, with higher risk in participants with eGFR values 105 mL·min-1·1.73 m-2, compared with those with eGFR between 60 and 105 mL·min-1·1.73 m-2. Mendelian randomization analyses for CHD showed an association among participants with eGFR 105 mL·min-1·1.73 m-2. Results were not materially different after adjustment for factors associated with the eGFR genetic risk score, such as lipoprotein(a), triglycerides, hemoglobin A1c, and blood pressure. Mendelian randomization results for stroke were nonsignificant but broadly similar to those for CHD. CONCLUSIONS: In people without manifest cardiovascular disease or diabetes, mild-to-moderate kidney dysfunction is causally related to risk of CHD, highlighting the potential value of preventive approaches that preserve and modulate kidney function.

Published
2022

6. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies

Author

Fontvieille, Emma, Viallon, Vivian, Recalde, Martina, Cordova, Reynalda, Jansana, Anna, Peruchet-Noray, Laia, Lennon, Hannah, Heath, Alicia K., Aune, Dagfinn, Christakoudi, Sofia, Katzke, Verena, Kaaks, Rudolf, Inan-Eroglu, Elif, Schulze, Matthias B., Mellemkjær, Lene, Tjønneland, Anne, Overvad, Kim, Farràs, Marta, Petrova, Dafina, Amiano, Pilar, Chirlaque, María-Dolores, Moreno-Iribas, Conchi, Tin Tin, Sandar, Masala, Giovanna, Sieri, Sabina, Ricceri, Fulvio, Panico, Salvatore, May, Anne M., Monninkhof, Evelyn M., Weiderpass, Elisabete, Gunter, Marc J., Ferrari, Pietro, and Freisling, Heinz

Published
2023
Full Text
View/download PDF

8. Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort

Author

Zhao, Yujia, Walker, Douglas I., Lill, Christina M., Bloem, Bastiaan R., Darweesh, Sirwan K. L., Pinto-Pacheco, Brismar, McNeil, Brooklyn, Miller, Gary W., Heath, Alicia K., Frissen, Myrthe, Petrova, Dafina, Sánchez, Maria-Jose, Chirlaque, María-Dolores, Guevara, Marcela, Zibetti, Maurizio, Panico, Salvatore, Middleton, Lefkos, Katzke, Verena, Kaaks, Rudolf, Riboli, Elio, Masala, Giovanna, Sieri, Sabina, Zamora-Ros, Raul, Amiano, Pilar, Jenab, Mazda, Peters, Susan, and Vermeulen, Roel

Published
2023
Full Text
View/download PDF

9. Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

Author

Lécuyer, Lucie, Laouali, Nasser, Viallon, Vivian, Artaud, Fanny, Hébert, James R., Shivappa, Nitin, Agudo, Antonio, Tjønneland, Anne, Mellemkjær, Lene, Kaaks, Rudolf, Katzke, Verena A., Schulze, Matthias B., Frenoy, Pauline, Mancini, Francesca Romana, De Magistris, Maria Santucci, Macciotta, Alessandra, Masala, Giovanna, Agnoli, Claudia, Tumino, Rosario, Boer, Jolanda M.A., Verschuren, W.M. Monique, Enget Jensen, Torill M., Olsen, Karina Standahl, Skeie, Guri, Chirlaque, María-Dolores, Petrova, Dafina, Castro-Espin, Carlota, Quirós, J. Ramón, Guevara, Marcela, Amiano, Pilar, Borné, Yan, Sandström, Maria, Nilsson, Lena Maria, Heath, Alicia K., Mayen, Ana-Lucia, Huybrechts, Inge, Weiderpass, Elisabete, Boutron-Ruault, Marie-Christine, Dossus, Laure, Rinaldi, Sabina, and Truong, Thérèse

Published
2023
Full Text
View/download PDF

11. Parental Risk Literacy Is Related to Quality of Life in Spanish Families of Children with Autism Spectrum Disorder

Author

Garrido, Dunia, Petrova, Dafina, Cokely, Edward, Carballo, Gloria, and Garcia-Retamero, Rocio

Abstract

Families of children with autism spectrum disorder (ASD) often experience much more negative perceptions of their family quality of life (FQoL). To investigate key factors that may shape these experiences, we conducted a case-control study of sixty-one Spanish families (29 with a child with ASD) using a broad psychosocial assessment (e.g., ASD severity, social support, demographics), including the first direct test of the relationship between FQoL and parental risk literacy (i.e., the ability to evaluate and understand risk, as measured by numeracy). Results revealed that numeracy was associated with differences in perceived FQoL among families of children with ASD (R[superscript 2] = 0.10), a finding that held across several models statistically controlling for the influence of other variables. Findings suggest that parental risk literacy skills may generally be associated with differences in decision making vulnerabilities (e.g., risk evaluation and interpretation) that influence family outcomes including FQoL.

Published
2021
Full Text
View/download PDF

12. Association between nutritional profiles of foods underlying Nutri-Score front-of-pack labels and mortality : EPIC cohort study in 10 European countries

Author

Deschasaux, Mélanie, Huybrechts, Inge, Julia, Chantal, Hercberg, Serge, Egnell, Manon, Srour, Bernard, Kesse-Guyot, Emmanuelle, Latino-Martel, Paule, Biessy, Carine, Casagrande, Corinne, Murphy, Neil, Jenab, Mazda, Ward, Heather A, Weiderpass, Elisabete, Overvad, Kim, Tjønneland, Anne, Rostgaard-Hansen, Agnetha Linn, Boutron-Ruault, Marie-Christine, Mancini, Francesca Romana, Mahamat-Saleh, Yahya, Kühn, Tilman, Katzke, Verena, Bergmann, Manuela M, Schulze, Matthias B, Trichopoulou, Antonia, Karakatsani, Anna, Peppa, Eleni, Masala, Giovanna, Agnoli, Claudia, DeMagistris, Maria Santucci, Tumino, Rosario, Sacerdote, Carlotta, Boer, Jolanda MA, Verschuren, WM Monique, vanderSchouw, Yvonne T, Skeie, Guri, Braaten, Tonje, Redondo, M Luisa, Agudo, Antonio, Petrova, Dafina, Colorado-Yohar, Sandra M, Barricarte, Aurelio, Amiano, Pilar, Sonestedt, Emily, Ericson, Ulrika, Otten, Julia, Sundström, Björn, Wareham, Nicholas J, Forouhi, Nita G, Vineis, Paolo, Tsilidis, Konstantinos K, Knuppel, Anika, Papier, Keren, Ferrari, Pietro, Riboli, Elio, Gunter, Marc J, and Touvier1, Mathilde

Published
2020

14. Dietary intake of dicarbonyl compounds and changes in body weight over time in a large cohort of European adults

Author

Debras, Charlotte, Cordova, Reynalda, Mayén, Ana-Lucia, Maasen, Kim, Knaze, Viktoria, Eussen, Simone Jpm, Schalkwijk, Casper G., Huybrechts, Inge, Tjønneland, Anne, Halkjær, Jytte, Katzke, Verena, Bajracharya, Rashmita, Schulze, Matthias B., Masala, Giovanna, Pala, Valeria, Pasanisi, Fabrizio, Macciotta, Alessandra, Petrova, Dafina, Castañeda, Jazmin, Santiuste, Carmen, Amiano, Pilar, Moreno-Iribas, Conchi, Borné, Yan, Sonestedt, Emily, Johansson, Ingegerd, Esberg, Anders, Aglago, Elom Kouassivi, Jenab, Mazda, Freisling, Heinz, Debras, Charlotte, Cordova, Reynalda, Mayén, Ana-Lucia, Maasen, Kim, Knaze, Viktoria, Eussen, Simone Jpm, Schalkwijk, Casper G., Huybrechts, Inge, Tjønneland, Anne, Halkjær, Jytte, Katzke, Verena, Bajracharya, Rashmita, Schulze, Matthias B., Masala, Giovanna, Pala, Valeria, Pasanisi, Fabrizio, Macciotta, Alessandra, Petrova, Dafina, Castañeda, Jazmin, Santiuste, Carmen, Amiano, Pilar, Moreno-Iribas, Conchi, Borné, Yan, Sonestedt, Emily, Johansson, Ingegerd, Esberg, Anders, Aglago, Elom Kouassivi, Jenab, Mazda, and Freisling, Heinz

Abstract

Dicarbonyl compounds are highly reactive precursors of Advanced Glycation End-products (AGEs), produced endogenously, present in certain foods, and formed during food processing. AGEs contribute to development of adverse metabolic outcomes but health effects of dietary dicarbonyls are largely unexplored. We investigated associations between three dietary dicarbonyl compounds, methylglyoxal (MGO), glyoxal (GO), and 3-deoxyglucosone (3-DG), and body-weight changes in European adults. Dicarbonyl intakes were estimated using food composition database from 263,095 EPIC-PANACEA participants with two body-weight assessments (median follow-up time=5.4y). Associations between dicarbonyls and 5-year body-weight changes were estimated using mixed linear regression models. Stratified analyses by sex, age, and baseline BMI were performed. Risk of becoming overweight/obese was assessed using multivariable-adjusted logistic regression. MGO intake was associated with 5-year body-weight gain of 0.089kg (per 1-SD increase, 95%CI=0.072, 0.107). 3-DG was inversely associated with body-weight change (-0.076kg, -0.094, -0.058). No significant association was observed for GO (0.018kg, -0.002, 0.037). In stratified analyses, GO was associated with body-weight gain among women and older participants (above median of 52.4y). MGO was associated with higher body-weight gain among older participants. 3-DG was inversely associated with body-weight gain among younger and normal-weight participants. MGO was associated with higher risk of becoming overweight/obese, while inverse associations were observed for 3-DG. No associations were observed for GO with overweight/obesity. Dietary dicarbonyls are inconsistently associated with body-weight change among European adults. Further research is needed to clarify the role of these food components in overweight and obesity, their underlying mechanisms, and potential public-health implications.

Published
2024
Full Text
View/download PDF

15. Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort

Author

Zhao, Yujia, Lai, Yunjia, Konijnenberg, Hilde, Huerta, José María, Vinagre-Aragon, Ana, Sabin, Jara Anna, Hansen, Johnni, Petrova, Dafina, Sacerdote, Carlotta, Zamora-Ros, Raul, Pala, Valeria, Heath, Alicia K, Panico, Salvatore, Guevara, Marcela, Masala, Giovanna, Lill, Christina M, Miller, Gary W, Peters, Susan, Vermeulen, Roel, Zhao, Yujia, Lai, Yunjia, Konijnenberg, Hilde, Huerta, José María, Vinagre-Aragon, Ana, Sabin, Jara Anna, Hansen, Johnni, Petrova, Dafina, Sacerdote, Carlotta, Zamora-Ros, Raul, Pala, Valeria, Heath, Alicia K, Panico, Salvatore, Guevara, Marcela, Masala, Giovanna, Lill, Christina M, Miller, Gary W, Peters, Susan, and Vermeulen, Roel

Abstract

BACKGROUND AND OBJECTIVES: Inverse associations between caffeine intake and Parkinson disease (PD) have been frequently implicated in human studies. However, no studies have quantified biomarkers of caffeine intake years before PD onset and investigated whether and which caffeine metabolites are related to PD.METHODS: Associations between self-reported total coffee consumption and future PD risk were examined in the EPIC4PD study, a prospective population-based cohort including 6 European countries. Cases with PD were identified through medical records and reviewed by expert neurologists. Hazard ratios (HRs) and 95% CIs for coffee consumption and PD incidence were estimated using Cox proportional hazards models. A case-control study nested within the EPIC4PD was conducted, recruiting cases with incident PD and matching each case with a control by age, sex, study center, and fasting status at blood collection. Caffeine metabolites were quantified by high-resolution mass spectrometry in baseline collected plasma samples. Using conditional logistic regression models, odds ratios (ORs) and 95% CIs were estimated for caffeine metabolites and PD risk.RESULTS: In the EPIC4PD cohort (comprising 184,024 individuals), the multivariable-adjusted HR comparing the highest coffee intake with nonconsumers was 0.63 (95% CI 0.46-0.88, p = 0.006). In the nested case-control study, which included 351 cases with incident PD and 351 matched controls, prediagnostic caffeine and its primary metabolites, paraxanthine and theophylline, were inversely associated with PD risk. The ORs were 0.80 (95% CI 0.67-0.95, p = 0.009), 0.82 (95% CI 0.69-0.96, p = 0.015), and 0.78 (95% CI 0.65-0.93, p = 0.005), respectively. Adjusting for smoking and alcohol consumption did not substantially change these results. DISCUSSION: This study demonstrates that the neuroprotection of coffee on PD is attributed to caffeine and its metabolites by detailed quantification of plasma caffeine a

Published
2024

16. Association of body shape phenotypes and body fat distribution indexes with inflammatory biomarkers in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank

Author

Cardiometabolic Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, González-Gil, Esther M., Peruchet-Noray, Laia, Sedlmeier, Anja M., Christakoudi, Sofia, Biessy, Carine, Navionis, Anne Sophie, Mahamat-Saleh, Yahya, Jaafar, Rola F., Baurecht, Hansjörg, Guevara, Marcela, Etxezarreta, Pilar Amiano, Verschuren, W. M.Monique, Boer, Jolanda M.A., Olsen, Anja, Tjønneland, Anne, Simeon, Vittorio, Castro-Espin, Carlota, Aune, Dagfinn, Heath, Alicia K., Gunter, Marc, Colorado-Yohar, Sandra M., Zilhão, Nuno R., Dahm, Christina C., Llanaj, Erand, Schulze, Matthias B., Petrova, Dafina, Sieri, Sabina, Ricceri, Fulvio, Masala, Giovanna, Key, Tim, Viallon, Vivian, Rinaldi, Sabina, Freisling, Heinz, Dossus, Laure, Cardiometabolic Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, González-Gil, Esther M., Peruchet-Noray, Laia, Sedlmeier, Anja M., Christakoudi, Sofia, Biessy, Carine, Navionis, Anne Sophie, Mahamat-Saleh, Yahya, Jaafar, Rola F., Baurecht, Hansjörg, Guevara, Marcela, Etxezarreta, Pilar Amiano, Verschuren, W. M.Monique, Boer, Jolanda M.A., Olsen, Anja, Tjønneland, Anne, Simeon, Vittorio, Castro-Espin, Carlota, Aune, Dagfinn, Heath, Alicia K., Gunter, Marc, Colorado-Yohar, Sandra M., Zilhão, Nuno R., Dahm, Christina C., Llanaj, Erand, Schulze, Matthias B., Petrova, Dafina, Sieri, Sabina, Ricceri, Fulvio, Masala, Giovanna, Key, Tim, Viallon, Vivian, Rinaldi, Sabina, Freisling, Heinz, and Dossus, Laure

Published
2024

17. Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries

Author

Cardiovasculaire Epi Team 1, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiometabolic Health, Tong, Tammy Y.N., Clarke, Robert, Schmidt, Julie A., Huybrechts, Inge, Noor, Urwah, Forouhi, Nita G., Imamura, Fumiaki, Travis, Ruth C., Weiderpass, Elisabete, Aleksandrova, Krasimira, Dahm, Christina C., van der Schouw, Yvonne T., Overvad, Kim, Kyrø, Cecilie, Tjønneland, Anne, Kaaks, Rudolf, Katzke, Verena, Schiborn, Catarina, Schulze, Matthias B., Mayen-Chacon, Ana Lucia, Masala, Giovanna, Sieri, Sabina, de Magistris, Maria Santucci, Tumino, Rosario, Sacerdote, Carlotta, Boer, Jolanda M.A., Verschuren, W. M.Monique, Brustad, Magritt, Nøst, Therese Haugdahl, Crous-Bou, Marta, Petrova, Dafina, Amiano, Pilar, Huerta, José María, Moreno-Iribas, Conchi, Engström, Gunnar, Melander, Olle, Johansson, Kristina, Lindvall, Kristina, Aglago, Elom K., Heath, Alicia K., Butterworth, Adam S., Danesh, John, Key, Timothy J., Cardiovasculaire Epi Team 1, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiometabolic Health, Tong, Tammy Y.N., Clarke, Robert, Schmidt, Julie A., Huybrechts, Inge, Noor, Urwah, Forouhi, Nita G., Imamura, Fumiaki, Travis, Ruth C., Weiderpass, Elisabete, Aleksandrova, Krasimira, Dahm, Christina C., van der Schouw, Yvonne T., Overvad, Kim, Kyrø, Cecilie, Tjønneland, Anne, Kaaks, Rudolf, Katzke, Verena, Schiborn, Catarina, Schulze, Matthias B., Mayen-Chacon, Ana Lucia, Masala, Giovanna, Sieri, Sabina, de Magistris, Maria Santucci, Tumino, Rosario, Sacerdote, Carlotta, Boer, Jolanda M.A., Verschuren, W. M.Monique, Brustad, Magritt, Nøst, Therese Haugdahl, Crous-Bou, Marta, Petrova, Dafina, Amiano, Pilar, Huerta, José María, Moreno-Iribas, Conchi, Engström, Gunnar, Melander, Olle, Johansson, Kristina, Lindvall, Kristina, Aglago, Elom K., Heath, Alicia K., Butterworth, Adam S., Danesh, John, and Key, Timothy J.

Published
2024

18. Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort

Author

IRAS OH Epidemiology Chemical Agents, IRAS – One Health Chemical, Zhao, Yujia, Lai, Yunjia, Konijnenberg, Hilde, Huerta, José María, Vinagre-Aragon, Ana, Sabin, Jara Anna, Hansen, Johnni, Petrova, Dafina, Sacerdote, Carlotta, Zamora-Ros, Raul, Pala, Valeria, Heath, Alicia K, Panico, Salvatore, Guevara, Marcela, Masala, Giovanna, Lill, Christina M, Miller, Gary W, Peters, Susan, Vermeulen, Roel, IRAS OH Epidemiology Chemical Agents, IRAS – One Health Chemical, Zhao, Yujia, Lai, Yunjia, Konijnenberg, Hilde, Huerta, José María, Vinagre-Aragon, Ana, Sabin, Jara Anna, Hansen, Johnni, Petrova, Dafina, Sacerdote, Carlotta, Zamora-Ros, Raul, Pala, Valeria, Heath, Alicia K, Panico, Salvatore, Guevara, Marcela, Masala, Giovanna, Lill, Christina M, Miller, Gary W, Peters, Susan, and Vermeulen, Roel

Published
2024

19. Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet)

Author

Locati, Laura, Cavalieri, Stefano, Dal Maso, Luigino, Busco, Susanna, Anderson, Lesley Ann, Botta, Laura, Bento, Maria José, Carulla, Marià, Chirlaque López, Maria Dolores, Fusco, Mario, Guevara, Marcela, Innos, Kaire, Børge Johannesen, Tom, Micallef, Rita, Minicozzi, Pamela, Panato, Chiara, Petrova, Dafina, Rubio-Casadevall, Jordi, Smailyte, Giedre, Francesca Vitale, Maria, and Trama, Annalisa

Published
2020
Full Text
View/download PDF

21. Dietary intake of dicarbonyl compounds and changes in body weight over time in a large cohort of European adults

Author

Debras, Charlotte, primary, Cordova, Reynalda, additional, Mayén, Ana-Lucia, additional, Maasen, Kim, additional, Knaze, Viktoria, additional, Eussen, Simone J. P. M., additional, Schalkwijk, Casper G., additional, Huybrechts, Inge, additional, Tjønneland, Anne, additional, Halkjær, Jytte, additional, Katzke, Verena, additional, Bajracharya, Rashmita, additional, Schulze, Matthias B., additional, Masala, Giovanna, additional, Pala, Valeria, additional, Pasanisi, Fabrizio, additional, Macciotta, Alessandra, additional, Petrova, Dafina, additional, Castañeda, Jazmin, additional, Santiuste, Carmen, additional, Amiano, Pilar, additional, Moreno-Iribas, Conchi, additional, Borné, Yan, additional, Sonestedt, Emily, additional, Johansson, Ingegerd, additional, Esberg, Anders, additional, Aglago, Elom Kouassivi, additional, Jenab, Mazda, additional, and Freisling, Heinz, additional

Published
2024
Full Text
View/download PDF

22. Health behavior and decision-making in healthcare

Author

Jarke, Hannes, primary, Ruggeri, Kai, additional, Graeber, Johanna, additional, Tünte, Markus R., additional, Ojinaga-Alfageme, Olatz, additional, Verra, Sanne, additional, Petrova, Dafina, additional, Benzerga, Amel, additional, Zupan, Zorana, additional, Galizzi, Matteo M., additional, Berge, Mari Louise, additional, Radukić, Andrijana, additional, Rosenthal, David, additional, Tomat, Nastja, additional, and Wang, Keying, additional

Published
2021
Full Text
View/download PDF

23. The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis

Author

Petrova, Dafina, Spacírová, Zuzana, Fernández-Martínez, Nicolás Francisco, Ching-López, Ana, Garrido, Dunia, Rodríguez-Barranco, Miguel, Pollán, Marina, Redondo-Sánchez, Daniel, Espina, Carolina, Higueras-Callejón, Camila, and Sánchez, Maria José

Subjects
Cancer -- Diagnosis -- Care and treatment, Biological sciences
Abstract

Background Longer time intervals to diagnosis and treatment are associated with worse survival for various types of cancer. The patient, diagnostic, and treatment intervals are considered core indicators for early diagnosis and treatment. This review estimated the median duration of these intervals for various types of cancer and compared it across high- and lower-income countries. Methods and findings We conducted a systematic review with meta-analysis (prospectively registered protocol CRD42020200752). Three databases (MEDLINE, Embase, and Web of Science) and information sources including grey literature (Google Scholar, OpenGrey, EThOS, ProQuest Dissertations & Theses) were searched. Eligible articles were published during 2009 to 2022 and reported the duration of the following intervals in adult patients diagnosed with primary symptomatic cancer: patient interval (from the onset of symptoms to first presentation to a healthcare professional), diagnostic interval (from first presentation to diagnosis), and treatment interval (from diagnosis to treatment start). Interval duration was recorded in days and study medians were combined in a pooled estimate with 95% confidence intervals (CIs). The methodological quality of studies was assessed using the Aarhus checklist. A total of 410 articles representing 68 countries and reporting on 5,537,594 patients were included. The majority of articles reported data from high-income countries (n = 294, 72%), with 116 (28%) reporting data from lower-income countries. Pooled meta-analytic estimates were possible for 38 types of cancer. The majority of studies were conducted on patients with breast, lung, colorectal, and head and neck cancer. In studies from high-income countries, pooled median patient intervals generally did not exceed a month for most cancers. However, in studies from lower-income countries, patient intervals were consistently 1.5 to 4 times longer for almost all cancer sites. The majority of data on the diagnostic and treatment intervals came from high-income countries. Across both high- and lower-income countries, the longest diagnostic intervals were observed for hematological (71 days [95% CI 52 to 85], e.g., myelomas (83 days [47 to 145])), genitourinary (58 days [50 to 77], e.g., prostate (85 days [57 to 112])), and digestive/gastrointestinal (57 days [45 to 67], e.g., colorectal (63 days [48 to 78])) cancers. Similarly, the longest treatment intervals were observed for genitourinary (57 days [45 to 66], e.g., prostate (75 days [61 to 87])) and gynecological (46 days [38 to 54], e.g., cervical (69 days [45 to 108]) cancers. In studies from high-income countries, the implementation of cancer-directed policies was associated with shorter patient and diagnostic intervals for several cancers. This review included a large number of studies conducted worldwide but is limited by survivor bias and the inherent complexity and many possible biases in the measurement of time points and intervals in the cancer treatment pathway. In addition, the subintervals that compose the diagnostic interval (e.g., primary care interval, referral to diagnosis interval) were not considered. Conclusions These results identify the cancers where diagnosis and treatment initiation may take the longest and reveal the extent of global disparities in early diagnosis and treatment. Efforts should be made to reduce help-seeking times for cancer symptoms in lower-income countries. Estimates for the diagnostic and treatment intervals came mostly from high-income countries that have powerful health information systems in place to record such information., Author(s): Dafina Petrova 1,2,3,*, Zuzana Spacírová 1,2,3, Nicolás Francisco Fernández-Martínez 1,2,3,4, Ana Ching-López 1,2,3, Dunia Garrido 5, Miguel Rodríguez-Barranco 1,2,3, Marina Pollán 3,6, Daniel Redondo-Sánchez 1,2,3, Carolina Espina 7, Camila [...]

Published
2022
Full Text
View/download PDF

25. Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries

Author

Tong, Tammy Y. N., primary, Clarke, Robert, additional, Schmidt, Julie A., additional, Huybrechts, Inge, additional, Noor, Urwah, additional, Forouhi, Nita G., additional, Imamura, Fumiaki, additional, Travis, Ruth C., additional, Weiderpass, Elisabete, additional, Aleksandrova, Krasimira, additional, Dahm, Christina C., additional, van der Schouw, Yvonne T., additional, Overvad, Kim, additional, Kyrø, Cecilie, additional, Tjønneland, Anne, additional, Kaaks, Rudolf, additional, Katzke, Verena, additional, Schiborn, Catarina, additional, Schulze, Matthias B., additional, Mayen-Chacon, Ana-Lucia, additional, Masala, Giovanna, additional, Sieri, Sabina, additional, de Magistris, Maria Santucci, additional, Tumino, Rosario, additional, Sacerdote, Carlotta, additional, Boer, Jolanda M. A., additional, Verschuren, W. M. Monique, additional, Brustad, Magritt, additional, Nøst, Therese Haugdahl, additional, Crous-Bou, Marta, additional, Petrova, Dafina, additional, Amiano, Pilar, additional, Huerta, José María, additional, Moreno-Iribas, Conchi, additional, Engström, Gunnar, additional, Melander, Olle, additional, Johansson, Kristina, additional, Lindvall, Kristina, additional, Aglago, Elom K., additional, Heath, Alicia K., additional, Butterworth, Adam S., additional, Danesh, John, additional, and Key, Timothy J., additional

Published
2023
Full Text
View/download PDF

27. Social support buffers the negative effects of stress in cardiac patients: a cross-sectional study with acute coronary syndrome patients

Author

Wiesmaierova, Simona, Petrova, Dafina, Arrebola Moreno, Antonio, Catena, Andrés, Ramírez Hernández, José Antonio, and Garcia-Retamero, Rocio

Subjects
Acute coronary syndrome -- Prognosis, Cardiac patients -- Psychological aspects -- Social aspects -- Health aspects, Social networks -- Health aspects -- Psychological aspects, Stress (Psychology) -- Health aspects -- Social aspects, Psychology and mental health
Abstract

Cardiac patients who have social support generally have better prognosis than patients who lack social support. Several theoretical mechanisms have been proposed to explain this protective effect, including the capacity of social support to buffer the negative effects of stress. We tested this buffering effect in a study of patients hospitalized for acute coronary syndrome (ACS) in Spain. Several days after the cardiac event patients answered a questionnaire measuring stressful events during their lifetime, perceived social support around the time of the cardiac event, and depression symptoms in the past week. Results showed that stressful life events were related to depressive symptoms and worse renal function post-ACS only among patients with low perceived social support. Among patients who reported enough social support, lifetime stress was not related to depressive symptoms. No similar effects were observed on other prognostic indicators such as troponin levels or the number of obstructed arteries. These results suggest that social support can buffer the negative effects of stress on the mental and physical well-being of cardiac patients., Author(s): Simona Wiesmaierova [sup.1] , Dafina Petrova [sup.1] [sup.2] [sup.3] [sup.4] , Antonio Arrebola Moreno [sup.5] , Andrés Catena [sup.1] , José Antonio Ramírez Hernández [sup.3] [sup.6] , Rocio Garcia-Retamero [...]

Published
2019
Full Text
View/download PDF

29. Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries

Author

Tong, Tammy Y.N., primary, Clarke, Robert, additional, Schmidt, Julie A., additional, Huybrechts, Inge, additional, Noor, Urwah, additional, Forouhi, Nita G., additional, Imamura, Fumiaki, additional, Travis, Ruth C., additional, Weiderpass, Elisabete, additional, Aleksandrova, Krasimira, additional, Dahm, Christina C., additional, van der Schouw, Yvonne T., additional, Overvad, Kim, additional, Kyrø, Cecilie, additional, Tjønneland, Anne, additional, Kaaks, Rudolf, additional, Katzke, Verena, additional, Schiborn, Catarina, additional, Schulze, Matthias B., additional, Mayen-Chacon, Ana-Lucia, additional, Masala, Giovanna, additional, Sieri, Sabina, additional, de Magistris, Maria Santucci, additional, Tumino, Rosario, additional, Sacerdote, Carlotta, additional, Boer, Jolanda M.A., additional, Verschuren, W.M. Monique, additional, Brustad, Magritt, additional, Nøst, Therese Haugdahl, additional, Crous-Bou, Marta, additional, Petrova, Dafina, additional, Amiano, Pilar, additional, Huerta, José María, additional, Moreno-Iribas, Conchi, additional, Engström, Gunnar, additional, Melander, Olle, additional, Johansson, Kristina, additional, Lindvall, Kristina, additional, Aglago, Elom K., additional, Heath, Alicia K., additional, Butterworth, Adam S., additional, Danesh, John, additional, and Key, Timothy J., additional

Published
2023
Full Text
View/download PDF

30. The duration of intervals on the oral cancer care pathway and implications for survival: a systematic review and meta-analysis

Author

Fernández-Martínez, Nicolás Francisco, primary, Petrova, Dafina, additional, Špacírová, Zuzana, additional, Barrios-Rodríguez, Rocío, additional, Pérez-Sayáns, Mario, additional, Martín-delosReyes, Luis Miguel, additional, Pérez-Gómez, Beatriz, additional, Rodríguez-Barranco, Miguel, additional, and Sánchez, María José, additional

Published
2023
Full Text
View/download PDF

31. Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development

Author

Saberi Hosnijeh, Fatemeh, Kolijn, Pieter M., Casabonne, Delphine, Nieters, Alexandra, Solans, Marta, Naudin, Sabine, Ferrari, Pietro, Mckay, James D., Weiderpass, Elisabete, Perduca, Vittorio, Besson, Caroline, Mancini, Francesca Romana, Masala, Giovanna, Krogh, Vittorio, Ricceri, Fulvio, Huerta, José M., Petrova, Dafina, Sala, Núria, Trichopoulou, Antonia, Karakatsani, Anna, La Vecchia, Carlo, Kaaks, Rudolf, Canzian, Federico, Aune, Dagfinn, Boeing, Heiner, Schulze, Matthias B., Perez-Cornago, Aurora, Langerak, Anton W., van der Velden, Vincent H. J., and Vermeulen, Roel

Published
2020
Full Text
View/download PDF

32. DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making

Author

Kabir, Misha, primary, Thomas-Gibson, Siwan, additional, Tozer, Phil J, additional, Warusavitarne, Janindra, additional, Faiz, Omar, additional, Hart, Ailsa, additional, Allison, Lisa, additional, Acheson, Austin G, additional, Atici, Semra Demirli, additional, Avery, Pearl, additional, Brar, Mantaj, additional, Carvello, Michele, additional, Choy, Matthew C, additional, Dart, Robin J, additional, Davies, Justin, additional, Dhar, Anjan, additional, Din, Shahida, additional, Hayee, Bu'Hussain, additional, Kandiah, Kesavan, additional, Katsanos, Konstantinos H, additional, Lamb, Christopher Andrew, additional, Limdi, Jimmy K, additional, Lovegrove, Richard E, additional, Myrelid, Pär, additional, Noor, Nurulamin, additional, Papaconstantinou, Ioannis, additional, Petrova, Dafina, additional, Pavlidis, Polychronis, additional, Pinkney, Thomas, additional, Proud, David, additional, Radford, Shellie, additional, Rao, Rohit, additional, Sebastian, Shaji, additional, Segal, Jonathan P, additional, Selinger, Christian, additional, Spinelli, Antonino, additional, Thomas, Kathryn, additional, Wolthuis, Albert, additional, and Wilson, Ana, additional

Published
2023
Full Text
View/download PDF

34. Allostatic Load and Depression Symptoms in Cancer Survivors

Author

Petrova, Dafina, primary, Ubago-Guisado, Esther, additional, Garcia-Retamero, Rocio, additional, Redondo-Sánchez, Daniel, additional, Pérez-Gómez, Beatriz, additional, Catena, Andrés, additional, Caparros-Gonzalez, Rafael A., additional, and Sánchez, Maria José, additional

Published
2023
Full Text
View/download PDF

35. DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making

Author

Kabir, Misha, Thomas-Gibson, Siwan, Tozer, Phil J., Warusavitarne, Janindra, Faiz, Omar, Hart, Ailsa, Allison, Lisa, Acheson, Austin G., Atici, Semra Demirli, Avery, Pearl, Brar, Mantaj, Carvello, Michele, Choy, Matthew C., Dart, Robin J., Davies, Justin, Dhar, Anjan, Din, Shahida, Hayee, BuHussain, Kandiah, Kesavan, Katsanos, Konstantinos H., Lamb, Christopher Andrew, Limdi, Jimmy K., Lovegrove, Richard E., Myrelid, Pär, Noor, Nurulamin, Papaconstantinou, Ioannis, Petrova, Dafina, Pavlidis, Polychronis, Pinkney, Thomas, Proud, David, Radford, Shellie, Rao, Rohit, Sebastian, Shaji, Segal, Jonathan P., Selinger, Christian, Spinelli, Antonino, Thomas, Kathryn, Wolthuis, Albert, Wilson, Ana, Kabir, Misha, Thomas-Gibson, Siwan, Tozer, Phil J., Warusavitarne, Janindra, Faiz, Omar, Hart, Ailsa, Allison, Lisa, Acheson, Austin G., Atici, Semra Demirli, Avery, Pearl, Brar, Mantaj, Carvello, Michele, Choy, Matthew C., Dart, Robin J., Davies, Justin, Dhar, Anjan, Din, Shahida, Hayee, BuHussain, Kandiah, Kesavan, Katsanos, Konstantinos H., Lamb, Christopher Andrew, Limdi, Jimmy K., Lovegrove, Richard E., Myrelid, Pär, Noor, Nurulamin, Papaconstantinou, Ioannis, Petrova, Dafina, Pavlidis, Polychronis, Pinkney, Thomas, Proud, David, Radford, Shellie, Rao, Rohit, Sebastian, Shaji, Segal, Jonathan P., Selinger, Christian, Spinelli, Antonino, Thomas, Kathryn, Wolthuis, Albert, and Wilson, Ana

Abstract

Background and Aims Inflammatory bowel disease colitis-associated dysplasia is managed with either enhanced surveillance and endoscopic resection or prophylactic surgery. The rate of progression to cancer after a dysplasia diagnosis remains uncertain in many cases and patients have high thresholds for accepting proctocolectomy. Individualised discussion of management options is encouraged to take place between patients and their multidisciplinary teams for best outcomes. We aimed to develop a toolkit to support a structured, multidisciplinary and shared decision-making approach to discussions about dysplasia management options between clinicians and their patients. Methods Evidence from systematic literature reviews, mixed-methods studies conducted with key stakeholders, and decision-making expert recommendations were consolidated to draft consensus statements by the DECIDE steering group. These were then subjected to an international, multidisciplinary modified electronic Delphi process until an a priori threshold of 80% agreement was achieved to establish consensus for each statement. Results In all, 31 members [15 gastroenterologists, 14 colorectal surgeons and two nurse specialists] from nine countries formed the Delphi panel. We present the 18 consensus statements generated after two iterative rounds of anonymous voting. Conclusions By consolidating evidence for best practice using literature review and key stakeholder and decision-making expert consultation, we have developed international consensus recommendations to support health care professionals counselling patients on the management of high cancer risk colitis-associated dysplasia. The final toolkit includes clinician and patient decision aids to facilitate shared decision-making.

Published
2023
Full Text
View/download PDF

36. Body mass index and cancer risk among adults with and without cardiometabolic diseases:evidence from the EPIC and UK Biobank prospective cohort studies

Author

Fontvieille, Emma, Viallon, Vivian, Recalde, Martina, Cordova, Reynalda, Jansana, Anna, Peruchet-Noray, Laia, Lennon, Hannah, Heath, Alicia K., Aune, Dagfinn, Christakoudi, Sofia, Katzke, Verena, Kaaks, Rudolf, Inan-Eroglu, Elif, Schulze, Matthias B., Mellemkjær, Lene, Tjønneland, Anne, Overvad, Kim, Farràs, Marta, Petrova, Dafina, Amiano, Pilar, Chirlaque, María Dolores, Moreno-Iribas, Conchi, Tin Tin, Sandar, Masala, Giovanna, Sieri, Sabina, Ricceri, Fulvio, Panico, Salvatore, May, Anne M., Monninkhof, Evelyn M., Weiderpass, Elisabete, Gunter, Marc J., Ferrari, Pietro, Freisling, Heinz, Fontvieille, Emma, Viallon, Vivian, Recalde, Martina, Cordova, Reynalda, Jansana, Anna, Peruchet-Noray, Laia, Lennon, Hannah, Heath, Alicia K., Aune, Dagfinn, Christakoudi, Sofia, Katzke, Verena, Kaaks, Rudolf, Inan-Eroglu, Elif, Schulze, Matthias B., Mellemkjær, Lene, Tjønneland, Anne, Overvad, Kim, Farràs, Marta, Petrova, Dafina, Amiano, Pilar, Chirlaque, María Dolores, Moreno-Iribas, Conchi, Tin Tin, Sandar, Masala, Giovanna, Sieri, Sabina, Ricceri, Fulvio, Panico, Salvatore, May, Anne M., Monninkhof, Evelyn M., Weiderpass, Elisabete, Gunter, Marc J., Ferrari, Pietro, and Freisling, Heinz

Abstract

Background Whether cancer risk associated with a higher body mass index (BMI), a surrogate measure of adiposity, differs among adults with and without cardiovascular diseases (CVD) and/or type 2 diabetes (T2D) is unclear. The primary aim of this study was to evaluate separate and joint associations of BMI and CVD/T2D with the risk of cancer. Methods This is an individual participant data meta-analysis of two prospective cohort studies, the UK Biobank (UKB) and the European Prospective Investigation into Cancer and nutrition (EPIC), with a total of 577,343 adults, free of cancer, T2D, and CVD at recruitment. We used Cox proportional hazard regressions to estimate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between BMI and incidence of obesity-related cancer and in turn overall cancer with a multiplicative interaction between BMI and the two cardiometabolic diseases (CMD). HRs and 95% CIs for separate and joint associations for categories of overweight/obesity and CMD status were estimated, and additive interaction was quantified through relative excess risk due to interaction (RERI). Results In the meta-analysis of both cohorts, BMI (per ~ 5 kg/m2) was positively associated with the risk of obesity-related cancer among participants without a CMD (HR: 1.11, 95%CI: 1.07,1.16), among participants with T2D (HR: 1.11, 95% CI: 1.05,1.18), among participants with CVD (HR: 1.17, 95% CI: 1.11,1.24), and suggestively positive among those with both T2D and CVD (HR: 1.09, 95% CI: 0.94,1.25). An additive interaction between obesity (BMI ≥ 30 kg/m2) and CVD with the risk of overall cancer translated into a meta-analytical RERI of 0.28 (95% CI: 0.09–0.47). Conclusions Irrespective of CMD status, higher BMI increased the risk of obesity-related cancer among European adults. The additive interaction between obesity and CVD suggests that obesity prevention would translate into a greater cance, Background: Whether cancer risk associated with a higher body mass index (BMI), a surrogate measure of adiposity, differs among adults with and without cardiovascular diseases (CVD) and/or type 2 diabetes (T2D) is unclear. The primary aim of this study was to evaluate separate and joint associations of BMI and CVD/T2D with the risk of cancer. Methods: This is an individual participant data meta-analysis of two prospective cohort studies, the UK Biobank (UKB) and the European Prospective Investigation into Cancer and nutrition (EPIC), with a total of 577,343 adults, free of cancer, T2D, and CVD at recruitment. We used Cox proportional hazard regressions to estimate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between BMI and incidence of obesity-related cancer and in turn overall cancer with a multiplicative interaction between BMI and the two cardiometabolic diseases (CMD). HRs and 95% CIs for separate and joint associations for categories of overweight/obesity and CMD status were estimated, and additive interaction was quantified through relative excess risk due to interaction (RERI). Results: In the meta-analysis of both cohorts, BMI (per ~ 5 kg/m2) was positively associated with the risk of obesity-related cancer among participants without a CMD (HR: 1.11, 95%CI: 1.07,1.16), among participants with T2D (HR: 1.11, 95% CI: 1.05,1.18), among participants with CVD (HR: 1.17, 95% CI: 1.11,1.24), and suggestively positive among those with both T2D and CVD (HR: 1.09, 95% CI: 0.94,1.25). An additive interaction between obesity (BMI ≥ 30 kg/m2) and CVD with the risk of overall cancer translated into a meta-analytical RERI of 0.28 (95% CI: 0.09–0.47). Conclusions: Irrespective of CMD status, higher BMI increased the risk of obesity-related cancer among European adults. The additive interaction between obesity and CVD suggests that obesity prevention would translate into a greater cancer risk reducti

Published
2023

37. Lipopolysaccharide-binding protein and future Parkinson's disease risk: a European prospective cohort

Author

IRAS OH Epidemiology Chemical Agents, IRAS – One Health Chemical, Zhao, Yujia, Walker, Douglas I, Lill, Christina M, Bloem, Bastiaan R, Darweesh, Sirwan K L, Pinto-Pacheco, Brismar, McNeil, Brooklyn, Miller, Gary W, Heath, Alicia K, Frissen, Myrthe, Petrova, Dafina, Sánchez, Maria-Jose, Chirlaque, María-Dolores, Guevara, Marcela, Zibetti, Maurizio, Panico, Salvatore, Middleton, Lefkos, Katzke, Verena, Kaaks, Rudolf, Riboli, Elio, Masala, Giovanna, Sieri, Sabina, Zamora-Ros, Raul, Amiano, Pilar, Jenab, Mazda, Peters, Susan, Vermeulen, Roel, IRAS OH Epidemiology Chemical Agents, IRAS – One Health Chemical, Zhao, Yujia, Walker, Douglas I, Lill, Christina M, Bloem, Bastiaan R, Darweesh, Sirwan K L, Pinto-Pacheco, Brismar, McNeil, Brooklyn, Miller, Gary W, Heath, Alicia K, Frissen, Myrthe, Petrova, Dafina, Sánchez, Maria-Jose, Chirlaque, María-Dolores, Guevara, Marcela, Zibetti, Maurizio, Panico, Salvatore, Middleton, Lefkos, Katzke, Verena, Kaaks, Rudolf, Riboli, Elio, Masala, Giovanna, Sieri, Sabina, Zamora-Ros, Raul, Amiano, Pilar, Jenab, Mazda, Peters, Susan, and Vermeulen, Roel

Published
2023

38. Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

Author

Cardiometabolic Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Lécuyer, Lucie, Laouali, Nasser, Viallon, Vivian, Artaud, Fanny, Hébert, James R, Shivappa, Nitin, Agudo, Antonio, Tjønneland, Anne, Mellemkjær, Lene, Kaaks, Rudolf, Katzke, Verena A, Schulze, Matthias B, Frenoy, Pauline, Mancini, Francesca Romana, De Magistris, Maria Santucci, Macciotta, Alessandra, Masala, Giovanna, Agnoli, Claudia, Tumino, Rosario, Boer, Jolanda M A, Verschuren, W M Monique, Enget Jensen, Torill M, Olsen, Karina Standahl, Skeie, Guri, Chirlaque, María-Dolores, Petrova, Dafina, Castro-Espin, Carlota, Quirós, J Ramón, Guevara, Marcela, Amiano, Pilar, Borné, Yan, Sandström, Maria, Nilsson, Lena Maria, Heath, Alicia K, Mayen, Ana-Lucia, Huybrechts, Inge, Weiderpass, Elisabete, Boutron-Ruault, Marie-Christine, Dossus, Laure, Rinaldi, Sabina, Truong, Thérèse, Cardiometabolic Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Lécuyer, Lucie, Laouali, Nasser, Viallon, Vivian, Artaud, Fanny, Hébert, James R, Shivappa, Nitin, Agudo, Antonio, Tjønneland, Anne, Mellemkjær, Lene, Kaaks, Rudolf, Katzke, Verena A, Schulze, Matthias B, Frenoy, Pauline, Mancini, Francesca Romana, De Magistris, Maria Santucci, Macciotta, Alessandra, Masala, Giovanna, Agnoli, Claudia, Tumino, Rosario, Boer, Jolanda M A, Verschuren, W M Monique, Enget Jensen, Torill M, Olsen, Karina Standahl, Skeie, Guri, Chirlaque, María-Dolores, Petrova, Dafina, Castro-Espin, Carlota, Quirós, J Ramón, Guevara, Marcela, Amiano, Pilar, Borné, Yan, Sandström, Maria, Nilsson, Lena Maria, Heath, Alicia K, Mayen, Ana-Lucia, Huybrechts, Inge, Weiderpass, Elisabete, Boutron-Ruault, Marie-Christine, Dossus, Laure, Rinaldi, Sabina, and Truong, Thérèse

Published
2023

39. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies

Author

Epi Kanker, Cancer, JC onderzoeksprogramma Kanker, Epi Kanker Team C, Fontvieille, Emma, Viallon, Vivian, Recalde, Martina, Cordova, Reynalda, Jansana, Anna, Peruchet-Noray, Laia, Lennon, Hannah, Heath, Alicia K, Aune, Dagfinn, Christakoudi, Sofia, Katzke, Verena, Kaaks, Rudolf, Inan-Eroglu, Elif, Schulze, Matthias B, Mellemkjær, Lene, Tjønneland, Anne, Overvad, Kim, Farràs, Marta, Petrova, Dafina, Amiano, Pilar, Chirlaque, María-Dolores, Moreno-Iribas, Conchi, Tin Tin, Sandar, Masala, Giovanna, Sieri, Sabina, Ricceri, Fulvio, Panico, Salvatore, May, Anne M, Monninkhof, Evelyn M, Weiderpass, Elisabete, Gunter, Marc J, Ferrari, Pietro, Freisling, Heinz, Epi Kanker, Cancer, JC onderzoeksprogramma Kanker, Epi Kanker Team C, Fontvieille, Emma, Viallon, Vivian, Recalde, Martina, Cordova, Reynalda, Jansana, Anna, Peruchet-Noray, Laia, Lennon, Hannah, Heath, Alicia K, Aune, Dagfinn, Christakoudi, Sofia, Katzke, Verena, Kaaks, Rudolf, Inan-Eroglu, Elif, Schulze, Matthias B, Mellemkjær, Lene, Tjønneland, Anne, Overvad, Kim, Farràs, Marta, Petrova, Dafina, Amiano, Pilar, Chirlaque, María-Dolores, Moreno-Iribas, Conchi, Tin Tin, Sandar, Masala, Giovanna, Sieri, Sabina, Ricceri, Fulvio, Panico, Salvatore, May, Anne M, Monninkhof, Evelyn M, Weiderpass, Elisabete, Gunter, Marc J, Ferrari, Pietro, and Freisling, Heinz

Published
2023

42. The science of behavior and decision-making

Author

Ruggeri, Kai, primary, Kunz, Marvin, additional, Berkessel, Jana, additional, Kácha, Ondřej, additional, Steinnes, Kamilla Knutsen, additional, Petrova, Dafina, additional, Cavassini, Filippo, additional, Naru, Faisal, additional, and Hardy, Elizabeth, additional

Published
2018
Full Text
View/download PDF

43. Health and healthcare

Author

Ruggeri, Kai, primary, Radukić, Andrijana, additional, Ojinaga-Alfageme, Olatz, additional, Benzerga, Amel, additional, Zupan, Zorana, additional, Verra, Sanne, additional, Petrova, Dafina, additional, and Rosenthal, David, additional

Published
2018
Full Text
View/download PDF

44. Sex Moderates the Relationship Between Social Support and Cardiovascular Prevention Behaviors in Middle-aged and Older Adults.

Author

Blakoe, Mitti, Petrova, Dafina, Garcia-Retamero, Rocio, Gonçalves, Karen, Catena, Andrés, Hernández, José Antonio Ramírez, and Sánchez, Maria José

Subjects
*MIDDLE-aged persons, *SOCIAL support, *OLDER people, *MIDDLE-aged men, *OLDER men
Abstract

Background Most risk factors for cardiovascular disease (CVD) are modifiable, suggesting that the burden of CVD could be substantially reduced through cardiovascular screening and healthier lifestyle. People who have social support are more likely to adhere to cardiovascular prevention recommendations, but it is not clear whether the benefit of social support is equal for men and women. Purpose We investigated whether sex moderates the relationship between social support and adherence to cardiovascular prevention recommendations in a nationally representative sample. Methods Participants were 17,287 adults (n = 10,264 middle-aged adults 40–64 years old and n = 7,023 older adults ≥ 65 years old) who participated in the National Health Survey of Spain in 2017. Social support was measured with the Functional Social Support Questionnaire of Duke-UNC. Adherence to cardiovascular screening recommendations was assessed based on self-reported testing of cholesterol, blood pressure, and blood sugar by a health professional in the past 12 months. Adherence to recommended health-related behaviors was assessed based on the guidelines of the European Society of Cardiology regarding diet, alcohol consumption, smoking, and physical activity. Results Multiple regression models adjusted for socio-demographic and cardiovascular history and risk variables showed that social support was more strongly associated with adherence to cardiovascular prevention recommendations in men than in women. In particular, low social support levels were especially detrimental for both middle-aged men (screening: B = 0.13, 95% CI [0.06–0.20], p <.001; behaviors: B = 0.33 [0.26–0.41], p <.001) and older men (screening: B = 0.10 [0.04–0.17], p =.001; behaviors: B = 0.16 [0.08–0.25], p <.001), whereas older women had comparatively high adherence, which was unrelated to social support (screening: B = 0.02 [−0.03 to 0.08], p =.433; behaviors: B = 0.03 [−0.03 to 0.10], p =.342). Conclusions Social support is more strongly associated with cardiovascular prevention in men than in women, such that men who lack social support have the lowest adherence to cardiovascular screening and lifestyle recommendations. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

46. Higher allostatic load is related to more depressive symptoms in cancer survivors

Author

Catena, Andrés, Rocio Garcia-Retamero, María-José Sánchez, Petrova, Dafina, Caparros-González, Rafael, Ubago-Guisado, Esther, Perez-Gomez, Beatriz, and Redondo-Sánchez, Daniel

Abstract

This is the data and code used for "Allostatic Load and Depression Symptoms in Cancer Survivors: A National Health and Nutrition Examination Survey Study" published in Cancer Nursing (DOI: 10.1097/NCC.0000000000001216).

Published
2023
Full Text
View/download PDF

47. Biomarkers for personalized prevention of chronic diseases

Author

Petrova, Dafina, Fernández-Martínez, Nicolás, Turner, Heather, Fernández-Navarro, Pablo, García-Esquinas, Esther García, Perez-Gomez, Beatriz, Sánchez, María José, Barahona-López, Cristina, Plans-Beriso, Elena, García-Ovejero, Ester, Artalejo, Fernando Rodríguez, Hernández, Orlando, Craciun, Oana, Pollán, Marina, Jiménez-Planet, Virginia, Kuhn, Isla, Diez, Paul, Kroese, Mark, Babb-De-Villiers, Chantal, Blackburn, Laura, and De Larrea, Nerea Fernández

Subjects
chronic diseases, rapid review, PROPHET project, cancer, biomarker, neurodegenerative diseases, scoping review, personalized prevention, cardiovascular diseases
Abstract

The “PeRsOnalized Prevention roadmap for the future HEalThcare” (PROPHET) project, funded by the European Union’s Horizon Europe research and innovation program and linked to ICPerMed, seeks to develop a Strategy Research and Innovation Agenda (SRIA) for the European Union. Find attached the protocol that corresponds to one of the first steps in the PROPHET, namely a review that aims to map the evidence and highlight the evidence gaps in research or use of biomarkers in personalized prevention in the general population, as well as their integration with digital technologies.

Published
2023
Full Text
View/download PDF

48. Biomarkers for personalized prevention of chronic diseases: protocol of a rapid scoping review

Author

Hernández, Orlando, Kuhn, Isla, Craciun, Oana, García-Esquinas, Esther García, Perez-Gomez, Beatriz, Kroese, Mark, Pollán, Marina, Fernández-Navarro, Pablo, Blackburn, Laura, Fernández-Martínez, Nicolás, De Larrea, Nerea Fernández, Diez, Paul, Sánchez, María José, García-Ovejero, Ester, Turner, Heather, Jiménez-Planet, Virginia, Petrova, Dafina, Babb-De-Villiers, Chantal, Plans-Beriso, Elena, Artalejo, Fernando Rodríguez, and Barahona-López, Cristina

Subjects
chronic diseases, rapid review, PROPHET project, Medicine and Health Sciences, cancer, biomarker, neurodegenerative diseases, scoping review, personalized prevention, cardiovascular diseases
Abstract

The “PeRsOnalized Prevention roadmap for the future HEalThcare” (PROPHET) project, funded by the European Union’s Horizon Europe research and innovation program and linked to ICPerMed, seeks to develop a Strategy Research and Innovation Agenda (SRIA) for the European Union. This protocol corresponds to one of the first steps in the PROPHET, namely a review that aims to map the evidence and highlight the evidence gaps in research or use of biomarkers in personalized prevention in the general population, as well as their integration with digital technologies.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results